查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1696274

日本医疗器材软体市场 - 2025 至 2033 年

Japan Software as a Medical Device Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

日本软体作为医疗器材市场在 2024 年达到 1,955 万美元，预计到 2033 年将达到 9,620 万美元，在 2025-2033 年预测期内的复合年增长率为 17.3%。

医疗设备软体（SaMD）专为医疗目的而设计，支援疾病诊断、治疗建议、患者监测和临床决策。它使用人工智慧、机器学习和云端运算等先进技术来改善医疗服务和患者治疗结果。 SaMD 可在智慧型手机、平板电脑或基于云端的系统等平台上独立运行，因此具有高度的可存取性和可扩展性。

市场动态：

驱动因素与约束因素

医疗保健领域云端运算和物联网 (IoT) 的整合日益加强

日本的软体即医疗设备 (SaMD) 市场正透过云端运算和物联网的融合发生重大转变。基于云端的平台为医疗资料提供安全储存、即时存取和进阶分析，从而提高效率和决策能力。物联网设备可实现持续的患者监测、远端诊断和早期疾病检测，从而减少医院就诊次数并改善患者的治疗效果。云端运算和物联网之间的协同作用正在加速创新、扩大市场机会并提高医疗保健的可近性。

老年病患和医护人员的数位素养有限

由于老年患者和医疗保健专业人员的数位素养有限，日本采用软体即医疗设备 (SaMD) 解决方案面临挑战。老龄化人口难以适应数位健康应用，限制了远端监控和人工智慧诊断的好处。传统医疗保健提供者可能也难以将 SaMD 工具整合到他们的工作流程中。缺乏数位化能力可能导致对新技术的抵制、软体使用不当以及对数位医疗解决方案的信任降低，从而减缓市场的成长。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按应用程式截取的程式码片段
  • 依指示摘录

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 医疗保健领域云端运算和物联网 (IoT) 的整合日益加强
      • 云端运算的进步
    • 限制
      • 老年病患和医护人员的数位素养有限
      • 支持性规范架构
    • 机会
      • 增加对健康科技新创企业的投资
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
  • 波特五力分析
  • 供应链分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章：按应用

  • 疾病管理
  • 诊断
  • 治疗监测
  • 预测健康分析
  • 其他的

第 6 章：按指征

  • 糖尿病
  • 心理健康
  • 肿瘤学
  • 心血管
  • 呼吸系统疾病
  • 其他的

第七章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第八章：公司简介

  • Japan Medical Device Corporation
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 关键进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Nipro Corporation
  • Micron, Inc
  • Olympus Medical Systems
  • Anaut Inc

第九章：假设和研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 10 章：附录

简介目录
Product Code: MD9375

The Japan software as a medical device market reached US$ 19.55 million in 2024 and is expected to reach US$ 96.20 million by 2033, growing at a CAGR of 17.3% during the forecast period 2025-2033.

Software as a Medical Device (SaMD) is designed for medical purposes, enabling disease diagnosis, treatment recommendations, patient monitoring, and clinical decision-making. It uses advanced technologies like AI, machine learning, and cloud computing to improve healthcare delivery and patient outcomes. SaMD operates independently on platforms like smartphones, tablets, or cloud-based systems, making it highly accessible and scalable.

Market Dynamics: Drivers & Restraints

Increasing Integration of Cloud Computing and the Internet of Things (IoT) in Healthcare

Japan's Software as a Medical Device (SaMD) market is being significantly transformed by the integration of cloud computing and IoT. Cloud-based platforms offer secure storage, real-time access, and advanced analytics for medical data, improving efficiency and decision-making. IoT devices enable continuous patient monitoring, remote diagnostics, and early disease detection, reducing hospital visits and improving patient outcomes. The synergy between cloud computing and IoT is accelerating innovation, expanding market opportunities, and improving healthcare accessibility.

Limited Digital Literacy Among Elderly Patients and Healthcare Professionals

The adoption of Software as a Medical Device (SaMD) solution in Japan faces challenges due to limited digital literacy among elderly patients and healthcare professionals. The aging population struggles with digital health applications, limiting the benefits of remote monitoring and AI-driven diagnostics. Traditional healthcare providers may also struggle to integrate SaMD tools into their workflows. This lack of digital proficiency can lead to resistance to new technologies, improper software utilization, and reduced trust in digital healthcare solutions, slowing the market's growth.

Segment Analysis

The Japan software as a medical device market is segmented based on application and indication.

Application:

The diagnostics from application segment is expected to dominate the software as a medical device market with the highest market share

Diagnostics is the process of identifying diseases, conditions, or medical abnormalities through various tests, assessments, and analyses. It includes imaging, laboratory testing, and clinical evaluations. Advancements in digital health now include AI-driven and software-based solutions, enhancing accuracy and efficiency. Effective diagnostics are crucial for preventive care, early intervention, and improving patient outcomes, guiding treatment decisions.

The diagnostics segment in this market is driven by the need for early disease detection, chronic conditions, AI-driven imaging, and data analytics. Remote diagnostics and telemedicine expansion improve healthcare accessibility. Regulatory approvals for AI-powered tools and cloud-based platforms support market growth.

The demand for cost-effective, accurate diagnostic solutions is driving SaMD adoption in precision medicine and personalized healthcare. Several companies are forming strategic partnerships to expand their diagnostic businesses. For instance, in January 2025, Monitor Corporation, a Korean medical AI company, partnered with Japanese digital healthcare provider Doctor-NET to sell its lung cancer diagnosis software in Japan. The AI-powered tool, MONCAD CTLN, aids radiologists in detecting lung cancer using chest CT scans. Doctor-NET has obtained manufacturing and sales certification for the software in Japan.

Competitive Landscape

The major Japan players in the software as a medical device market include Japan Medical Device Corporation, Nipro Corporation, Micron, Inc., Olympus Medical Systems and Anaut Inc. among others.

Key Developments

  • In May 2024, Anaut Inc., a surgical support software developer, received regulatory approval for its innovative medical device, "Eureka a," from the Ministry of Health, Labour and Welfare in Japan. The device, designed with advanced artificial intelligence, is set to revolutionize surgical practices.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan software as a medical device market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Application
  • 2.4. Snippet by Indication

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Integration of Cloud Computing and the Internet of Things (IoT) In Healthcare
      • 3.1.1.2. Advancements in Cloud Computing
    • 3.1.2. Restraints
      • 3.1.2.1. Limited Digital Literacy Among Elderly Patients and Healthcare Professionals
      • 3.1.2.2. Supportive Regulatory Framework
    • 3.1.3. Opportunity
      • 3.1.3.1. Increased Investment in HealthTech Startups
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. SWOT Analysis
  • 4.9. Unmet Needs and Gaps
  • 4.10. Recommended Strategies for Market Entry and Expansion
  • 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.12. Pricing Analysis and Price Dynamics
  • 4.13. Key Opinion Leaders

5. By Application

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 5.1.2. Market Attractiveness Index, By Application
  • 5.2. Disease Management*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Diagnostics
  • 5.4. Treatment Monitoring
  • 5.5. Predictive Health Analytics
  • 5.6. Others

6. By Indication

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 6.1.2. Market Attractiveness Index, By Indication
  • 6.2. Diabetes*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Mental Health
  • 6.4. Oncology
  • 6.5. Cardiovascular
  • 6.6. Respiratory Conditions
  • 6.7. Others

7. Competitive Landscape and Market Positioning

  • 7.1. Competitive Overview and Key Market Players
  • 7.2. Market Share Analysis and Positioning Matrix
  • 7.3. Strategic Partnerships, Mergers & Acquisitions
  • 7.4. Key Developments in Product Portfolios and Innovations
  • 7.5. Company Benchmarking

8. Company Profiles

  • 8.1. Japan Medical Device Corporation*
    • 8.1.1. Company Overview
    • 8.1.2. Product Portfolio
      • 8.1.2.1. Product Description
      • 8.1.2.2. Product Key Performance Indicators (KPIs)
      • 8.1.2.3. Historic and Forecasted Product Sales
      • 8.1.2.4. Product Sales Volume
    • 8.1.3. Financial Overview
      • 8.1.3.1. Company Revenue's
      • 8.1.3.2. Geographical Revenue Shares
      • 8.1.3.3. Revenue Forecasts
    • 8.1.4. Key Developments
      • 8.1.4.1. Mergers & Acquisitions
      • 8.1.4.2. Key Product Development Activities
      • 8.1.4.3. Regulatory Approvals, etc.
    • 8.1.5. SWOT Analysis
  • 8.2. Nipro Corporation
  • 8.3. Micron, Inc
  • 8.4. Olympus Medical Systems
  • 8.5. Anaut Inc

LIST NOT EXHAUSTIVE

9. Assumption and Research Methodology

  • 9.1. Data Collection Methods
  • 9.2. Data Triangulation
  • 9.3. Forecasting Techniques
  • 9.4. Data Verification and Validation

10. Appendix

  • 10.1. About Us and Services
  • 10.2. Contact Us